Associate professor of neurology, and program director, Headache Medicine Fellowship program, Medstar Georgetown University Hospital
Novel Approaches to Challenges in Treating Migraine: Carrie Dougherty, MD, FAHS
The program director of the Medstar Georgetown University Hospital Headache Medicine Fellowship program discussed the potential of INP104 to improve migraine patient care.
Investigating INP104 for Migraine Treatment: Carrie Dougherty, MD, FAHS
The program director of the Medstar Georgetown University Hospital Headache Medicine Fellowship program discussed further research to be conducted with the nasal delivery of DHE.
Nasal Delivery of DHE for Migraine: Carrie Dougherty, MD, FAHS
The program director of the Medstar Georgetown University Hospital Headache Medicine Fellowship program discussed the advantages of INP104 over other forms of dihydroergotamine.
STOP 301 Study of INP104 for Migraine: Carrie Dougherty, MD, FAHS
The program director of the Medstar Georgetown University Hospital Headache Medicine Fellowship program discussed the findings of the STOP 301 study.
Single-Center Study Provides Support for Natalizumab Use in Pregnant Women With Multiple Sclerosis
CMSC Poster Gives Demographic Insights for Phase 3 PERSEUS Study of Tolebrutinib
CMSC Live: 2025 Annual Meeting Day 1
Tracking Therapeutic Progress of Gene-Editing Agent PBGENE-DMD for Duchenne Muscular Dystrophy